Cardiac Resynchronization Therapy (CRT) stands at the forefront of advanced cardiac interventions, offering a targeted solution for individuals grappling with heart failure. This sophisticated therapy involves the implantation of a specialized device, often a pacemaker, with the aim of harmonizing the contractions of the heart's ventricles. By precisely orchestrating these contractions, CRT addresses the synchronization challenges that often accompany heart failure, ultimately boosting the heart's efficiency. Through the optimized timing of electrical impulses, CRT enhances the heart's pumping capability, resulting in improved blood flow and overall cardiovascular function. The transformative impact of CRT is evident in its ability to alleviate symptoms, enhance exercise tolerance, and elevate the overall quality of life for many patients. This therapeutic approach continues to redefine the landscape of cardiac care, offering hope and improved outcomes for individuals navigating the complexities of heart failure.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation